This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Multi-Center, Randomized, Controlled, Two-Arm, P...
Clinical trial

A Multi-Center, Randomized, Controlled, Two-Arm, Pivotal Phase III Study to Evaluate the Safety and Efficacy of MK-3475 Compared to Ipilimumab in Patients with Advanced Melanoma

Read time: 1 mins
Last updated:18th Jan 2013
To evaluate the overall survival (OS) in patients with advanced MEL receiving either MK-3475 or IPI.
Category Value
Study start date 2013-01-18

View full details